Doctors at the University of California’s flagship San Francisco hospital are sharply divided over a proposal to join forces with a Catholic-run system that restricts care on the basis of religious doctrine — part of a broader public debate as Catholic hospitals expand their reach.
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
California regularly portrays itself as a national trendsetter on political issues, and Gov. Gavin Newsom is claiming that title on prescription drugs. Newsom has a plan to take on the drug industry, and at an April 17 news conference in Southern California, he declared that two other governors already want to join his effort. […]
It’s as shady as it sounds.
A legal battle in Pennsylvania is testing the boundaries of health care competition and government action to oversee and regulate it.
Whistleblower lawsuits accuse Tennessee chain of bilking millions from Medicare for unnecessary urine drug tests.
Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the latest news about women’s reproductive health policy and the latest skirmish in the debate over “Medicare-for-all”: how hospitals should be paid.
Jennifer Haberkorn of the Los Angeles Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to answer listener questions about the fate of the Affordable Care Act, “Medicare-for-all“ and how to talk about health care costs. Also, for extra credit, the panelists offer their favorite “extra credit” stories of the week.
Hospitals and nursing homes in California and Illinois hope that regional cooperation — and a special soap — will help them gain the upper hand against deadly antibiotic-resistant superbugs.
